When Ipamorelin binds to GHS-R1a, it triggers an intracellular signaling cascade: Receptor activation Ipamorelin binds the GHS-R1a receptor on pituitary somatotrophs Phospholipase C pathway Gq/11 protein coupling activates PLC, generating IP3 and DAG Calcium mobilization IP3-mediated calcium release from intracellular stores triggers GH vesicle exocytosis Pulsatile GH release Growth hormone is released in a physiological pulsatile pattern, preserving hypothalamic feedback A critical distinction in Ipamorelin's mechanism is that it preserves the hypothalamic-pituitary feedback axis
However, this comes with a massive caveat that we can't stress enough: there are no large-scale, peer-reviewed human clinical trials published as of 2026 that specifically study the safety and efficacy of this exact combination
In addition to its anti-inflammatory properties, it is a natural aromatase inhibitor (43), an enzyme involved in the synthesis of estradiol and has also antiproliferative and anti-oxidant properties (44)
Treatments like chemical peels, laser therapy, and other topical skin-lightening products work by exfoliating the skin and reducing the appearance of hyperpigmentation
111 The purported role of 5-HT 2A antagonism in mediating cyproheptadines beneficial effect is interesting, given that there appears to be an association between 5-HT 2A antagonists themselves in the form of SGAs and the risk of SS